Otsuka’s Pharma Sales Surge as Tolvaptan Grows Six-Fold in North America

Otsuka President Tatsuo Higuchi Otsuka Holdings’ pharmaceutical revenue in 2019 soared over 13% from the previous year as the strong momentum of its four global brands remained unabated, with US sales of tolvaptan driving up the drug’s North American number...read more